Nidek MP1 is able to detect subtle decline in function in inherited and age-related atrophic macular disease with stable visual acuity

Retina

Volumn 31, Issue 2, 2011, Pages 371-379

  Chen, Fred K ^a,b   Patel, Praveen J ^a,b   Webster, Andrew R ^a,b   Coffey, Peter J ^a,b   Tufail, Adnan ^a,b   Da Cruz, Lyndon ^a,b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AMD; detection of disease progression; geographic atrophy; macular dystrophy; Microperimetry; retinal dystrophy

Indexed keywords

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; EYE FIXATION; FEMALE; FUNCTIONAL ANATOMY; HUMAN; HUMAN CELL; MALE; NIDEK MP1 MICROPERIMETER; PERIMETER; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SCOTOMA; VISUAL ACUITY;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FIXATION, OCULAR; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; OPHTHALMOSCOPY; RETINAL DISEASES; RETINAL DYSTROPHIES; RETROSPECTIVE STUDIES; SCOTOMA; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 79551530620     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181e46af3     Document Type: Article

References (35)

1. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 2008;27:536-548.
2. Chalam KV, Gupta SK, Shah GY, Agarwal S. Successful management of melanocytoma-associated choroidal neovascularization with photodynamic therapy. Eur J Ophthalmol 2006;16:776-778.
3. Yodoi Y, Tsujikawa A, Kameda T, et al. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007;143:984-994.
4. Richter-Mueksch S, Vecsei-Marlovits PV, Sacu SG, Kiss CG, Weingessel B, Schmidt-Erfurth U. Functional macular mapping in patients with vitreomacular pathologic features before and after surgery. Am J Ophthalmol 2007;144:23-31.
5. Rensch F, Spandau UH, Schlichtenbrede F, et al. Intravitreal bevacizumab for myopic choroidal neovascularization. Ophthalmic Surg Lasers Imaging 2008;39:182-185.
6. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008;358:2231-2239.
7. Issa PC, Finger RP, Holz FG, Scholl HP. Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol 2008;92:941-945.
8. Yenerel NM, Kucumen B, Gorgun E, Dinc UA. Atypical presentation of multiple evanescent white dot syndrome (MEWDS). Ocul Immunol Inflamm 2008;16:113-115.
9. Chen FK,Uppal GS, RubinGS,Webster AR, Coffey PJ, da Cruz L. Evidence of retinal function using microperimetry following autologous retinal pigment epithelium-choroid graft in macular dystrophy. Invest Ophthalmol Vis Sci 2008;49:3143-3150.
10. Ma Z, Han L, Wang C, et al. Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:2975-2981.
11. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008;146:172-182.
12. Parravano M, Oddone F, Tedeschi M, et al. Retinal functional changes measured by microperimetry in neovascular agerelated macular degeneration patients treated with ranibizumab. Retina 2009;29:329-334.
13. Yodoi Y, Tsujikawa A, Nakanishi H, et al. Central retinal sensitivity after intravitreal injection of bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol 2009; 147:816-824.
14. Yamaike N, Tsujikawa A, Sakamoto A, et al. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 2009;29:757-767.
15. Sunness JS, Schuchard RA, Shen N, Rubin GS, Dagnelie G, Haselwood DM. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci 1995;36:1863-1874.
16. Sunness JS, Applegate CA, Haselwood D, Rubin GS. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 1996;103:1458-1466.
17. Sunness JS, Margalit E, Srikumaran D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: Enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 2007;114:271-277.
18. Sunness JS, Bressler NM, Tian Y, Alexander J, Applegate CA. Measuring geographic atrophy in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 1999;40: 1761-1769.
19. Midena E, Degli AC, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 1997;38:469-477.
20. Scholl HP, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci 2004;45:574-583.
21. Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol 2007;91:1499-1503.
22. Parisi V, Perillo L, Tedeschi M, et al. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration. Retina 2007;27:879-890.
23. Jarc-VidmarM, Popovic P, HawlinaM.Mapping of central visual function by microperimetry and autofluorescence in patients with Best's vitelliform dystrophy. Eye 2006;20:688-696.
24. Popovic P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2005; 243:1018-1027.
25. Holladay JT. Visual acuity measurements. J Cataract Refract Surg 2004;30:287-290.
26. Chen FK, Patel PJ, Xing W, et al. Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 2009;50:3464-3472.
27. Steinman RM. Effect of target size, luminance, and color on monocular fixation. J Opt Soc Am 1965;55:1158-1165.
28. Tarita-Nistor L, Gonzalez EG, Markowitz SN, Steinbach MJ. Fixation characteristics of patients with macular degeneration recorded with the mp-1 microperimeter. Retina 2008;28:125-133.
29. Bewick V, Cheek L, Ball J. Statistics review 10: Further nonparametric methods. Crit Care 2004;8:196-199.
30. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 2006;103:3896-3901.
31. Merin S, Obolensky A, Farber MD, Chowers I. A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies. J Ocul Pharmacol Ther 2008;24:80-86.
32. Coleman H, Chew E. Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 2007;18:220-223.
33. Schmitz-Valckenberg S, Ong EE, Rubin GS, et al. Structural and functional changes over time in MacTel patients. Retina 2009;29:1314-1320.
34. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 1987;105:1544-1549.
35. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S. Progression of geographic atrophy and impact of fundus autofluorescence patterns in agerelated macular degeneration. Am J Ophthalmol 2007;143: 463-472.